Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

1(50.0%)

Phase 4

1(50.0%)

2Total

N/A(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT07026513Recruiting

ORal Aminaphtone and Combined LidocainE

Role: lead

NCT06638814Not Yet Recruiting

HEmorrhoidAl Disease in Inflammatory Bowel Disease: a Multicenter Prospective Cohort Study

Role: lead

NCT06495762Not Yet Recruiting

Preventing Premature Family Maladjustment: an e-Health Interdisciplinary Research

Role: collaborator

NCT05637788Active Not Recruiting

Artificial Intelligence and Hepatocellular Carcinoma

Role: collaborator

NCT05871242Not ApplicableCompleted

Study to Investigate the Treatment Benefit of Probiotic Lactobacillus Crispatus M247 in Women Undergoing Homologous Level 2 Assisted Reproductive Technology (ART) Procedures

Role: collaborator

NCT05616455Phase 4Completed

Efficacy and Safety of Propionibacterium Extract Gel Versus 0.4% Glyceryl Trinitrate Ointment in the Treatment of Chronic Anal Fissure: a Randomised Controlled Trial

Role: lead

NCT04541238Unknown

Imaging Template for Reporting Anal Fistula

Role: lead

NCT04488549Completed

Delayed Colorectal Cancer Care During Coronavirus Disease (COVID-19) Pandemic (DECOR-19)

Role: lead

All 8 trials loaded